[go: up one dir, main page]

DE60022663D1 - Verfahren zur herstellung von cox-2 inhibitoren - Google Patents

Verfahren zur herstellung von cox-2 inhibitoren

Info

Publication number
DE60022663D1
DE60022663D1 DE60022663T DE60022663T DE60022663D1 DE 60022663 D1 DE60022663 D1 DE 60022663D1 DE 60022663 T DE60022663 T DE 60022663T DE 60022663 T DE60022663 T DE 60022663T DE 60022663 D1 DE60022663 D1 DE 60022663D1
Authority
DE
Germany
Prior art keywords
general formula
compound
reacting
iii
cox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60022663T
Other languages
English (en)
Other versions
DE60022663T2 (de
Inventor
Laetitia Canali
Paul Cruciani
Gilles Oddon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Merial SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial SAS filed Critical Merial SAS
Publication of DE60022663D1 publication Critical patent/DE60022663D1/de
Application granted granted Critical
Publication of DE60022663T2 publication Critical patent/DE60022663T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60Two oxygen atoms, e.g. succinic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/19Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to acyclic carbon atoms of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Steroid Compounds (AREA)
DE60022663T 1999-10-08 2000-10-05 Verfahren zur herstellung von cox-2 inhibitoren Expired - Lifetime DE60022663T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9912583A FR2799462B1 (fr) 1999-10-08 1999-10-08 Procede de preparation d'inhibiteurs cox-2
FR9912583 1999-10-08
PCT/FR2000/002770 WO2001027098A2 (fr) 1999-10-08 2000-10-05 Procede de preparation d'inhibiteurs cox-2

Publications (2)

Publication Number Publication Date
DE60022663D1 true DE60022663D1 (de) 2005-10-20
DE60022663T2 DE60022663T2 (de) 2006-06-22

Family

ID=9550723

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60022663T Expired - Lifetime DE60022663T2 (de) 1999-10-08 2000-10-05 Verfahren zur herstellung von cox-2 inhibitoren

Country Status (11)

Country Link
US (1) US6541646B2 (de)
EP (1) EP1218366B8 (de)
JP (1) JP4933012B2 (de)
AT (1) ATE304537T1 (de)
AU (1) AU773221B2 (de)
CA (1) CA2386807C (de)
DE (1) DE60022663T2 (de)
DK (1) DK1218366T3 (de)
ES (1) ES2249299T3 (de)
FR (1) FR2799462B1 (de)
WO (1) WO2001027098A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7531002B2 (en) * 2004-04-16 2009-05-12 Depuy Spine, Inc. Intervertebral disc with monitoring and adjusting capabilities
US8541362B2 (en) 2005-08-19 2013-09-24 Emisphere Technologies, Inc. Cyclopropyl compounds and compositions for delivering active agents
EP2833390A1 (de) 2013-08-02 2015-02-04 Fei Company Verwendung von elektrostatischen Objektivlinsen in einem Elektronenmikroskop
CN104803956A (zh) * 2015-03-06 2015-07-29 江苏天和制药有限公司 非罗考昔的一种合成方法
CN105859664A (zh) * 2016-05-03 2016-08-17 中国药科大学 非罗考昔的一种制备方法
CN107641108A (zh) * 2017-11-12 2018-01-30 韦韬 一种非罗考昔的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA57002C2 (uk) * 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
HRP970289A2 (en) * 1996-05-31 1998-04-30 Merck & Co Inc Process for preparing phenyl heterocycles useful as cox-2 inhibitors
ATE244232T1 (de) * 1997-03-14 2003-07-15 Merck Frosst Canada Inc (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer
GB2330833A (en) * 1997-10-29 1999-05-05 Merck & Co Inc PREPARATION OF 4-(4-Methylsulfonylphenyl)-2-furanones USEFUL AS COX-2 INHIBITORS

Also Published As

Publication number Publication date
US20030028036A1 (en) 2003-02-06
AU773221B2 (en) 2004-05-20
EP1218366A2 (de) 2002-07-03
EP1218366B1 (de) 2005-09-14
US6541646B2 (en) 2003-04-01
JP2003511444A (ja) 2003-03-25
JP4933012B2 (ja) 2012-05-16
CA2386807C (en) 2010-03-30
EP1218366B8 (de) 2005-11-09
DK1218366T3 (da) 2006-01-23
WO2001027098A3 (fr) 2001-08-30
CA2386807A1 (en) 2001-04-19
ATE304537T1 (de) 2005-09-15
ES2249299T3 (es) 2006-04-01
WO2001027098A2 (fr) 2001-04-19
FR2799462A1 (fr) 2001-04-13
AU7794400A (en) 2001-04-23
DE60022663T2 (de) 2006-06-22
FR2799462B1 (fr) 2004-05-28

Similar Documents

Publication Publication Date Title
RU2009113019A (ru) Способы получения 1,2,4-оксадиазолбензойных кислот
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
DE602004019329D1 (de) Verfahren zur herstellung substituierter nikotinsäureester
DE60022663D1 (de) Verfahren zur herstellung von cox-2 inhibitoren
DK1515962T3 (da) Fremgangsmåde til fremstilling af dioxaneddikesyreestere
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE477227T1 (de) Verfahren zur herstellung eines trans-4-amino-1- cyclohexancarbonsäurederivats
ATE240309T1 (de) Ein verfahren zur stereoselektiven reduktion von alpha,beta-ungesättigten ketonen
RU2004130300A (ru) Способ синтеза хиральных n-арилпиперазинов
DE69802388D1 (de) Verfahren zur herstellung von nicotinsäuren
ATE244224T1 (de) Verfahren zur umwandlung von 2,4-dichlorpyridinen in 2-aryloxy-4-chlorpyridine
DE60012165D1 (de) Verfahren zur herstellung von alendron-säure
ATE384067T1 (de) Verfahren zur herstellung von 3-cephemderivaten
RU2005129993A (ru) Способ получения энантиомерных форм производных 1,3-циклогександиола в цис-конфигурации
ATE363460T1 (de) Verfahren zur herstellung von fluorhalogenalkanen
DE602004014822D1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
ATE282589T1 (de) Verfahren zur herstellung eines chiralen-beta- aminosäureesters
ATE61329T1 (de) Verfahren zur herstellung von rooperol, hypoxosid und deren derivaten.
ATE190979T1 (de) Verfahren zur produktion von thiophospholipiden des aether-typs
ATE520679T1 (de) Verfahren zur herstellung von (dioxolenon-4- yl)methylester-derivate
ATE345348T1 (de) Verfahren zur herstellung cyclischer organowasserstoffsiloxane
ATE313531T1 (de) Verfahren zur herstellung von hexahydropyridazin- 3-carbonsäure-derivaten
DK1196622T3 (da) Anvendelse af orthoestere til syntese af chirale syrer i biokatalyserede irreversible esterificeringsfremgangsmåder
ATE256099T1 (de) Verfahren zur herstellung einer kristallsuspensionhenonen
ATE259774T1 (de) Verfahren zur herstellung von 6,6-dialkoxy-5- hydroxy-3-oxo-hexansäureestern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition